May 01, 2008

Classic Mediterranean Kaposi’s Sarcoma Regression With Sirolimus Treatment

Author Affiliations

Copyright 2008 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2008

Arch Dermatol. 2008;144(5):692-693. doi:10.1001/archderm.144.5.692

Replacement of mycophenolate mofetil, cyclosporine, or tacrolimus by sirolimus results in regression of Kaposi's sarcoma (KS) in organ transplant recipients.13 In these patients, clearance from KS might result either from reduced immunosuppression or from the direct antiangiogenic effects of sirolimus.

First Page Preview View Large
First page PDF preview
First page PDF preview